TDG Five-Test Programme Resilient Gut System Gut Health Testing Food Sensitivity Testing What is an FDN-P? Recommended Resources Books Blog Book a Call
Insufficiency Series
Insufficiency Series · Part 2 · Blood Chemistry

Vitamin D Insufficiency —
The Gap Between Normal and Functional

Your vitamin D came back normal. But the reference range was set using populations with widespread insufficiency, 25-OH-D measures storage not conversion, and the number tells you nothing about VDR sensitivity, kidney function, magnesium status, or whether the active hormonal form is reaching the tissues that need it. The number is the beginning of the question, not the answer.

Stephen Duncan
BSc (Hons) · PG Dip · MSc · FDN-P
July 2026

A client brings in blood results from their GP. Vitamin D: 48 nmol/L. Reported as normal. They have fatigue, low mood, recurrent infections, muscle aching, and difficulty concentrating. Their GP has suggested they may be slightly stressed.

48 nmol/L is above the conventional deficiency threshold of 25–30 nmol/L. It therefore clears the reference range and is reported as normal. But 48 nmol/L is not functional sufficiency. It is the lower edge of a range that was set using populations in which widespread insufficiency had already shifted the average downward — the same methodological problem we have discussed in the context of ferritin.

More fundamentally: 48 nmol/L of 25-hydroxyvitamin D (the storage form measured by a standard blood test) tells you what is in storage. It tells you nothing about conversion to the active hormonal form, nothing about whether that conversion is proceeding normally, nothing about how sensitive the vitamin D receptor is in this person's tissues, and nothing about the magnesium and K2 status that determines whether the converted D is being directed appropriately. It is one data point in a system with multiple variables, and it is being treated as the whole story.

What 25-OH-D actually measures — and what it doesn't

Vitamin D operates through a two-step conversion sequence before it has any biological effect. Understanding this sequence is not an optional detail. It is the clinical argument for why a blood test that returns a "normal" 25-OH-D result can coexist with genuine functional insufficiency.

The Vitamin D Conversion Pathway
Skin synthesis: UVB radiation converts 7-dehydrocholesterol in skin to pre-vitamin D3, which becomes cholecalciferol (vitamin D3). This requires adequate UVB (not available at Scottish latitudes October–March), sufficient skin exposure time, no glass or sunscreen blocking UVB, and a delay before washing — the precursor sits in the skin for up to 48 hours before absorption.
Liver hydroxylation → 25-OH-D (calcidiol): The liver converts D3 to 25-hydroxyvitamin D — the storage form measured by standard blood tests. This is what your GP measures. It reflects recent dietary intake and supplementation as well as skin synthesis. It is a storage marker, not a functional marker.
Kidney hydroxylation → 1,25-OH-D (calcitriol): The kidneys convert 25-OH-D to 1,25-dihydroxyvitamin D — calcitriol — the active hormonal form that actually acts on cells. This conversion is regulated by PTH, calcium, phosphate, and FGF23. Kidney dysfunction, inflammation, or certain autoimmune conditions can disrupt this conversion independently of 25-OH-D levels.
Vitamin D receptor (VDR) activation: Calcitriol binds to the VDR in target tissues to produce biological effect. VDR expression and sensitivity vary significantly between individuals — partly genetic (VDR polymorphisms are common), partly driven by magnesium status (magnesium is required for VDR function), and partly by the inflammatory environment of the tissue.
The standard blood test measures step 2. The biological effect happens at step 4. Two people with identical 25-OH-D results can have very different functional vitamin D status depending on their kidney conversion, their VDR genetics, their magnesium sufficiency, and their inflammatory load. The number is the beginning of the clinical question, not the answer to it.

Why vitamin D does far more than bones

The public understanding of vitamin D is almost entirely framed around bone health — calcium absorption, rickets, osteoporosis prevention. This is accurate but represents perhaps 20% of what vitamin D actually does in the body. The discovery of VDR expression in nearly every cell type has expanded the clinical picture considerably.

IMMUNE
Immune Regulation
VDR is expressed on T cells, B cells, macrophages, and dendritic cells. Vitamin D modulates both innate and adaptive immunity — enhancing pathogen defence while down-regulating excessive inflammatory responses. Low vitamin D is consistently associated with increased susceptibility to respiratory infection and autoimmune conditions.
MOOD
Neurotransmitter Synthesis
Vitamin D regulates genes involved in serotonin and dopamine synthesis. VDR is expressed throughout the brain. The association between low vitamin D and depression, seasonal affective disorder, and cognitive decline is well documented — the mechanism runs through neurotransmitter production rather than simply mood as a downstream symptom.
MUSCLE
Muscle Function
VDR is expressed in muscle tissue. Vitamin D insufficiency impairs muscle protein synthesis, reduces fast-twitch fibre function, and increases fall risk in older adults. Proximal muscle weakness — difficulty rising from a chair, climbing stairs — is a documented consequence of insufficiency that frequently precedes any bone effect.
INSULIN
Glucose Metabolism
VDR is expressed in pancreatic beta cells. Vitamin D supports insulin secretion and insulin sensitivity. Low vitamin D is independently associated with increased type 2 diabetes risk and impaired glucose tolerance — relevant when blood sugar dysregulation and vitamin D insufficiency co-present on the same panel.
THYROID
Thyroid Function
Vitamin D regulates thyroid hormone receptor expression and modulates the immune response in autoimmune thyroid conditions (Hashimoto's, Graves'). Low vitamin D is highly prevalent in both conditions. The relationship is not simply correlational — VDR polymorphisms affect autoimmune thyroid susceptibility.
GUT
Gut Barrier Integrity
VDR is expressed throughout the intestinal epithelium. Vitamin D supports tight junction protein expression — the same proteins that zonulin disrupts in intestinal permeability. Low vitamin D is associated with increased gut permeability and dysbiosis. The gut-vitamin D relationship runs in both directions.

The reference range problem — again

The conventional lower threshold for vitamin D sufficiency in the UK is typically 50 nmol/L, with deficiency defined as below 25–30 nmol/L. These thresholds were set primarily with bone health endpoints in mind — the level at which rickets and osteomalacia risk is minimised. They were not set with immune function, neurotransmitter synthesis, muscle function, or glucose metabolism as endpoints. When those systems are the clinical concern, the threshold is insufficient.

The Methodological Problem
Reference ranges for 25-OH-D were derived from population samples that included significant numbers of vitamin D-insufficient people — particularly in northern European countries where UVB availability is limited for five to six months of the year. The resulting reference range reflects the statistical distribution of a partially insufficient population, not an optimally sufficient one. This is the same methodological issue as ferritin: normal means common, not optimal.

Functional ranges — what the evidence supports for non-bone endpoints

25-OH-D LevelConventional StatusFunctional AssessmentClinical Significance
Below 25 nmol/LDeficientClinically deficientRisk of rickets, osteomalacia, severe immune impairment. Immediate clinical priority.
25–50 nmol/LLow-normalFunctionally insufficientPasses conventional threshold. Immune function, neurotransmitter synthesis, muscle function, and glucose metabolism likely impaired. Symptom cluster consistent with insufficiency common in this range.
50–75 nmol/LNormalBorderline functionalAdequate for bone endpoints. Evidence suggests non-bone systems benefit from higher levels. GrassrootsHealth data shows health outcomes improving up to 100–125 nmol/L in most populations.
75–150 nmol/LNormalFunctional optimal rangeRange where immune, neurological, metabolic, and musculoskeletal endpoints all appear well supported. Target for repletion in most clinical contexts. Individual variation within this range.
Above 150 nmol/LHighCaution warrantedNo established benefit above this level for most people. Risk of hypercalcaemia with prolonged very high supplementation. Requires clinical justification and monitoring.

What needs to be in place for vitamin D to work properly

Vitamin D does not act alone. The full mineral regulatory system — calcium, magnesium, phosphate, PTH, and K2 — must be operating correctly for vitamin D to be converted efficiently and directed appropriately. Two cofactors deserve particular attention.

Magnesium is required for vitamin D activation (both hydroxylation steps), for VDR function, and for the enzymes involved in vitamin D metabolism. Supplementing vitamin D without adequate magnesium is like pressing the accelerator with the engine oil warning light on. The conversion happens poorly, and some of the downstream signalling is impaired. Most people supplementing vitamin D are also magnesium-insufficient — because the food supply depletes both, and because the stress-demand relationship amplifies magnesium deficiency.

Vitamin K2 directs calcium to bone and teeth rather than to soft tissues and arterial walls. High-dose vitamin D increases calcium absorption significantly. Without adequate K2, that calcium may deposit in arteries rather than bones — the mechanism behind concerns about vitamin D supplementation in isolation. Food-based K2 (fermented dairy, natto) or K2 as MK-7 supplementation alongside D3 is the clinical standard for anyone supplementing vitamin D.

"Vitamin D is a hormone precursor operating within a mineral regulatory system. Treating it as a standalone supplement — a number to raise, a capsule to take — misses the clinical picture almost entirely."

The individual variation principle

Every principle in this post comes with the same caveat: individual variation is real, significant, and clinically relevant. Two people with identical 25-OH-D results may have very different functional vitamin D status depending on their VDR genetics, their kidney conversion capacity, their magnesium status, their inflammatory load, and their baseline requirements. A result that represents functional sufficiency for one person may represent functional insufficiency for another.

This is why the clinical position on vitamin D is not "everyone needs a specific dose" or "everyone needs a specific level." It is: test first, address the cofactors, supplement to functional sufficiency confirmed by retesting, and adjust based on individual response. The target range is a guide. The individual data is the clinical reality.

Vitamin D is one of 150+ markers on the TDG blood chemistry panel

Interpreted alongside magnesium, calcium, PTH, inflammatory markers, and the full metabolic picture — so the number makes clinical sense rather than being read in isolation. The full vitamin D story, including what drives insufficiency in this specific person, requires the full clinical picture.

See the TDG Programme →